ResearcherUniversity at Buffalo, State University of New YorkActive in the last 2 years
Jin Niu
Matched on ORCID iD 0000-0003-4960-1598; OpenAlex author ID A5103052258. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 5
- Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness. Co-author DOI 10.1016/j.drup.2024.101064↗
- Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Cancer Patient-Derived Xenografts with Comb… First author DOI 10.1021/acs.jproteome.3c00164↗
- FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. First author DOI 10.1208/s12248-022-00752-8↗
- Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. Co-author DOI 10.1186/s12885-020-07398-9↗
- Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonS… First author DOI 10.1074/mcp.ra117.000519↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert M. Straubinger · 5 shared papers, 2018–2024 · strength 0.82
- Paper Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Can… DOI 10.1021/acs.jproteome.3c00164↗
- Paper Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven agg… DOI 10.1016/j.drup.2024.101064↗
- Paper FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. DOI 10.1208/s12248-022-00752-8↗
- Jun Qu · 4 shared papers, 2018–2024 · strength 0.67
- Paper Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Can… DOI 10.1021/acs.jproteome.3c00164↗
- Paper Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven agg… DOI 10.1016/j.drup.2024.101064↗
- Paper Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. DOI 10.1186/s12885-020-07398-9↗
- Xue Wang · 2 shared papers, 2018–2023 · strength 0.31
- Paper Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Can… DOI 10.1021/acs.jproteome.3c00164↗
- Paper Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Cur… DOI 10.1074/mcp.ra117.000519↗
- Donald E. Mager · 2 shared papers, 2020–2022 · strength 0.30
- Tista Roy Chaudhuri · 1 shared paper, 2024 · strength 0.22
- Qingxiang Lin · 1 shared paper, 2024 · strength 0.22
- Wen Wee Ma · 1 shared paper, 2024 · strength 0.22
- Taylor J. Allen-Coyle · 1 shared paper, 2022 · strength 0.15
- Sandra Roche · 1 shared paper, 2022 · strength 0.15
- Finbarr O’Sullivan · 1 shared paper, 2022 · strength 0.15
- Martin M. Clynes · 1 shared paper, 2022 · strength 0.15
- Xue Wang · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.